Foreign investors also extended their net selling streak for the third consecutive session, offloading nearly VNĐ356.3 trillion worth of shares on HoSE.
Recent announcements concerning state-owned enterprise share sales have sparked a series of positive performances, marking these stocks as bright spots on the trading screens.
The sale of Vincom Nguyễn Chí Thanh, valued at around VNĐ3.6 trillion, is expected to significantly bolster the company’s financial performance, with profits recorded in the fourth quarter of 2025.
This initiative aims to spotlight companies focused on delivering shareholder value through consistent dividend payments and robust financial performance.
This surge in profitability comes as the industry benefits from stabilising domestic demand and improving international prices, along with a in raw material costs.
As foreign investment rises and deal values surge, experts warn that complex regulations and inconsistent legal frameworks remain major barriers to healthcare M&A growth in Việt Nam.
While some firms are restructuring or focusing on the domestic market, a strategy that appears to be yielding positive results, others are still caught in a cycle of losses and financial distress.
Of the total shares distributed, about 202.16 million were acquired by 19,670 domestic investors, while 150,809 shares were allocated to 23 foreign investors.
